Syngene Board Approves Unaudited Financial Results for Q2 2026
Syngene International’s Board of Directors has approved the unaudited financial results for Q2 2026. Consolidated revenue reached ₹9,106…
Piramal Pharma Reports Unaudited Standalone Financial Results for Q2 2026
Piramal Pharma Limited announced its unaudited standalone financial results for the quarter and half-year ended September 30, 2025. The…
Continental Coffee To Acquire 26% Stake in Mukkonda Renewables
Continental Coffee has announced an amendment to its earlier plan to acquire a stake in Mukkonda Renewables Private Limited. Instead of a…
Syngene Q2 FY26 Revenue Rises 2% to ₹911 Crore
Syngene International reports a 2% year-on-year increase in revenue for Q2 FY26, reaching ₹911 Crore. First half revenue grew by 6%. The…
Syngene Board Approves Unaudited Financial Results for Q2 2026
Syngene International’s Board of Directors has approved the unaudited financial results for the quarter and half-year ended September…
Signature Global Sapan Bebarta Resigns as President – Legal
Signature Global announces the resignation of Sapan Bebarta from his position as President – Legal, effective from the close of business…
Sun Pharma Investor Call Audio Recording Available
Sun Pharmaceutical Industries Limited has announced that the audio recording of its investor call held on November 5, 2025, is now available…
Astral Limited Completes 80% Acquisition of Nexelon Chem Private Limited
Astral Limited has successfully completed the acquisition of an 80% equity stake in Nexelon Chem Private Limited. The acquisition, initially…
Continental Coffee Board Approves Q2 FY26 Results & Renewable Energy Investment
Continental Coffee has announced its Q2 FY26 results, showing strong standalone revenue of ₹559.18 million. The board has also approved an…
Aurobindo Pharma Reports Q2 FY26 Results, Revenue Up 6.3%
Aurobindo Pharma announced its consolidated financial results for the second quarter of FY26, ended September 30, 2025. Revenue from…